ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase I Study of Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Subjects With Metastatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00363454
Recruitment Status : Completed
First Posted : August 15, 2006
Last Update Posted : August 9, 2016
Sponsor:
Collaborator:
VioQuest Pharmaceuticals
Information provided by (Responsible Party):
Prescient Therapeutics, Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2010
  Actual Study Completion Date : September 2010